NCT07891273

Brief Summary

Intensive care unit-acquired weakness (ICU-AW) is a common complication of critical illness and can negatively affect recovery and long-term physical functioning. Early and reliable assessment of muscle strength is essential for detecting muscle weakness and monitoring changes during an intensive care unit (ICU) stay. However, conventional strength assessments, such as manual muscle testing, require voluntary muscle contractions, making them unsuitable for patients who are not yet cooperative and limiting the possibility of assessing muscle strength during the early stages of critical illness. Magnetic femoral nerve stimulation offers an alternative, non-volitional approach to assessing quadriceps muscle strength. Nevertheless, the reliability and validity of this technique in critically ill patients remain insufficiently established. This prospective methodological study aims to investigate the reliability and convergent validity of quadriceps twitch force measurements obtained using magnetic femoral nerve stimulation in critically ill patients. A total of 33 cooperative adult patients admitted to medical or surgical ICUs will be included. Participants will undergo repeated quadriceps twitch force assessments over two consecutive days, performed by two assessors. Measurements will be conducted using a custom-developed frame designed to facilitate standardized quadriceps strength assessment at the bedside. Both single and paired magnetic stimulation techniques will be evaluated. The primary outcome is the intra-rater reliability of paired twitch force measurements. Secondary outcomes include the inter-rater reliability of paired twitch force measurements, the intra-rater and inter-rater reliability of single twitch force measurements, and the convergent validity of twitch force measurements assessed through their association with maximal voluntary contraction force and potentiated twitch force. Reliability and agreement will be evaluated using intraclass correlation coefficients and complementary measurement error analyses. Establishing these measurement properties could support objective, non-volitional muscle strength assessment in critically ill patients, including those unable to participate in conventional strength testing. This could facilitate early baseline strength assessment, longitudinal monitoring of muscle recovery, and the evaluation of interventions aimed at preventing or treating ICU-AW..

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Dec 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 23, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2026

Expected
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

October 23, 2026

Status Verified

October 1, 2026

Enrollment Period

5 months

First QC Date

October 16, 2026

Last Update Submit

October 16, 2026

Conditions

Keywords

critical illnessICU-acquired weaknessfemoral nerve magnetic stimulationquadriceps muscle strengthnon-volitional muscle strength assessment

Outcome Measures

Primary Outcomes (1)

  • Intra-rater reliability of paired quadriceps twitch force measurements

    Intra-rater reliability of paired quadriceps twitch force measurements will be assessed using the intraclass correlation coefficient (ICC) with 95% confidence intervals, comparing measurements performed by the same assessor on two consecutive days. Measurement error and agreement will additionally be evaluated using the standard error of measurement (SEM), minimal detectable change (MDC95), and Bland-Altman analysis.

    Day 1 and Day 2 (two consecutive days)

Secondary Outcomes (7)

  • Inter-rater reliability of paired quadriceps twitch force measurements

    Day 2 (morning and afternoon)

  • Intra-rater reliability of single quadriceps twitch force measurements

    Day 1 and Day 2 (two consecutive days)

  • Inter-rater reliability of single quadriceps twitch force measurements

    Day 2 (morning and afternoon)

  • Convergent validity of single twitch force with maximal voluntary contraction

    Day 1

  • Convergent validity of paired twitch force with maximal voluntary contraction

    Day 1

  • +2 more secondary outcomes

Study Arms (1)

Magnetic Femoral Nerve Stimulation

EXPERIMENTAL

All participants will undergo quadriceps muscle strength assessments over two consecutive days, following the same standardized measurement sequence. On the first day, the first assessor will perform single and paired twitch force measurements using magnetic femoral nerve stimulation, alongside maximal voluntary contraction and potentiated twitch force assessments. On the second day, single and paired twitch force measurements will be repeated by the first assessor in the morning and by a second assessor in the afternoon to evaluate intra-rater and inter-rater reliability.

Diagnostic Test: Magnetic Femoral Nerve Stimulation

Interventions

Participants will be positioned prone in their hospital bed, with the knee flexed at approximately 90° using a dedicated measurement setup. A magnetic stimulation coil will be placed over the femoral nerve to elicit involuntary quadriceps muscle contractions. The resulting twitch force will be measured using a strain gauge dynamometer attached at the ankle. Stimulation intensity will be progressively increased to establish supramaximal stimulation, after which both single and paired magnetic stimuli will be applied to assess quadriceps twitch force.

Magnetic Femoral Nerve Stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Voluntary written informed consent of the participant has been obtained prior to the initiation of any study-related measurements
  • Adults (≥18 years)
  • Expected to remain in the ICU for more than an additional 2 days starting from study enrolment
  • Fully cooperative, as assessed daily during routine clinical care by ICU physiotherapists using five standardized commands ("open/close your eyes", "look at me", "open your mouth and stick out your tongue", "nod your head", and "raise your eyebrows when I have counted to 5")
  • Quadriceps muscle strength of at least 3/5 on the Medical Research Council (MRC) scale for knee extension.

You may not qualify if:

  • Medical instability A: Cardiorespiratory instability
  • Mean arterial pressure \< 60 mmHg or \> 110 mmHg
  • Fraction of inspired oxygen (FiO₂) ≥ 60%
  • PaO₂/FiO₂ ratio \< 200
  • Respiratory rate \> 30 breaths·min-¹ B: Neurological instability
  • Intracranial pressure \> 20 mmHg
  • Cerebral perfusion pressure \< 70 mmHg C: Surgery within the past 24h D: Body temperature \> 40
  • Contraindications to magnetic stimulation A: Implanted metal or electronic devices, including
  • Lower limb prostheses
  • Internal and external fixation devices of the lower limb
  • Vascular stents
  • Cardiac pacemakers or defibrillators
  • Implanted nerve stimulators B: Lower limb structural, skin, or soft tissue conditions
  • Acute or chronic injuries
  • Wounds preventing supine positioning
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Co-investigator, associate professor

Study Record Dates

First Submitted

October 16, 2026

First Posted

October 23, 2026

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

October 23, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share